Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer)

Published:2012-06-20 Issue:9 Volume:21 Page:1005-1012
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Tifratene Karim¹²,Duff Franck Le¹,Pradier Christian¹,Quetel Julien¹,Lafay Pierre³,Schück Stéphane⁴,Benzenine Eric⁵,Quantin Catherine⁵⁶,Robert Philippe²,

Affiliation:

1. CHU de Nice, Public Health Department; Nice France

2. CMRR-EA CoBTeK-CHU; Université de Nice Sophia Antipolis; Nice France

3. Ellipse; Nice France

4. Kappa Santé; Paris France

5. CHRU, Service de Biostatistique et d'Informatique Médicale; CHU de Dijon France

6. Universite de Bourgogne; Dijon France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3303/fullpdf

Reference29 articles.

1. Alzheimer's Disease;Cummings;N Engl J Med,2004

2. Rivastigmine for Alzheimer's disease;Birks;Cochrane Database Syst Rev,2009

3. Donepezil for dementia due to Alzheimer's disease;Birks;Cochrane Database Syst Rev,2006

4. Memantine for dementia;McShane;Cochrane Database Syst Rev,2006

5. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials;Kaduszkiewicz;BMJ,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data;Current Medical Research and Opinion;2023-03-11

2. Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease;Biomolecules;2022-07-17

3. Proposition of a corrected measure of the Lawton instrumental activities of daily living score;BMC Geriatrics;2021-01-12

4. Removal of Drugs for Alzheimer’s Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA);Drugs & Aging;2021-01

5. Description of the Treatment Course by Pregabalin for Anxiety in Patients With a Major Neurocognitive Disorder;Journal of Clinical Psychopharmacology;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3